Valiant Laboratories Limited (BOM:543998)

India · Delayed Price · Currency is INR

121.40

-3.55 (-2.84%)

At close: Oct 7, 2026

Market Cap	6.56B +44.4%
Revenue (ttm)	3.06B +89.6%
Net Income	160.14M +12,314.1%
EPS	2.95 +9,817.7%
Shares Out	n/a
PE Ratio	42.18
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,786
Open	124.95
Previous Close	124.95
Day's Range	120.55 - 124.95
52-Week Range	50.00 - 131.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Valiant Laboratories

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also manufactures and sells specialty chemicals and chemical intermediates, including chlorophenol derivatives, benzene-based specialty chemicals and other chemical intermediates to agroche... [Read more]

Industry Pharmaceutical Preparations

Founded 1980

Employees 84

Stock Exchange Bombay Stock Exchange

Ticker Symbol 543998

Full Company Profile

Financial Performance

In fiscal year 2026, Valiant Laboratories's revenue was 2.37 billion, an increase of 78.04% compared to the previous year's 1.33 billion. Losses were -32.68 million, 48.5% more than in 2025.

Financial Statements